Skip to main content

Urolithiasis

Ausgabe 6/2003

Inhalt (10 Artikel)

Original Article

Cellular fibronectin in patients with transitional cell carcinoma of the bladder

Axel Hegele, Axel Heidenreich, Zoltan Varga, Rolf von Knobloch, Peter Olbert, Jürgen Kropf, Rainer Hofmann

Original Article

Rapamycin induces Smad activity in prostate cancer cell lines

H. van der Poel, C. Hanrahan, H. Zhong, J. Simons

Original Article

Involvement of cyclic nucleotides in renal artery smooth muscle relaxation

A. Karsten, H. Derouet, M. Ziegler, R. Eckert

Original Paper

Ki67, gelsolin and PTEN expression in sarcomatoid renal tumors

Harri Visapää, David Seligson, Yunda Huang, Jian Rao, Arie Belldegrun, Steve Horvath, Aarno Palotie

Invited Editorial

The role of angiogenesis in prostate development and the pathogenesis of prostate cancer

David Hrouda, David Nicol, Robert Gardiner

Original Paper

Serum levels of basic fibroblast growth factor reflect disseminated disease in patients with testicular germ cell tumors

Wassilios Bentas, Wolf-Dietrich Beecken, Wolfgang Glienke, Jochen Binder, Horst Schuldes

Original Paper

Treatment of stress urinary incontinence: recent developments in the role of urethral injection

Philip van Kerrebroeck, Flip ter Meulen, Elisabeth Farrelly, Gregor Larsson, Lena Edwall, Aino Fianu-Jonasson

Original Paper

Botulinum toxin type A may improve bladder function in a rat chemical cystitis model

Selahittin Çayan, Banu Coşkun, Murat Bozlu, Deniz Acar, Erdem Akbay, Ercüment Ulusoy

Original Paper

Granulocyte colony-stimulating factor for the treatment of biomaterial-associated staphylococcal infections in-vitro

Andrea Schlöbe, Norbert Schnitzler, Klaus Schweizer, Detlef Rohde

Neu im Fachgebiet Urologie

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Prostatakarzinom: EU initiiert neues Screeningkonzept

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Blasenkarzinom – Biomarker statt Zytologie?

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.